Your blood vessels
have a language.
Flavanols speak it.
For thousands of years, cacao was used as medicine. Today, clinical science confirms what ancient civilisations understood. This page explains exactly how it works, and why most people have never received the dose that matters.
Where VitalCacao comes from
Not all cacao is the same. The variety, origin and processing of the bean determines how much of its therapeutic potential survives to your cup.
The Criollo bean, and why variety matters
There are three main varieties of cacao: Forastero, Trinitario and Criollo. Forastero accounts for approximately 80% of global cocoa production. It is hardy, high-yield, and flavanol-poor.
Criollo represents less than 5% of global production and is significantly richer in the epicatechin and procyanidin flavanols responsible for cardiovascular benefit. VitalCacao sources exclusively from single-origin Criollo farms.
Single-origin means we know the farm, the altitude, the fermentation method, and the drying time. Every variable that determines flavanol concentration is traceable.
How flavanols lower blood pressure
The mechanism is specific, well-documented and measurable. This is not a wellness claim — it is a biochemical pathway with a 20-year body of peer-reviewed evidence.
You drink VitalCacao
600–800mg of flavanols enter your digestive system. The full-matrix form in whole cacao maximises intestinal absorption versus isolated supplements.
Flavanols reach the endothelium
Epicatechin is absorbed within 30–60 minutes and reaches the endothelium — the single-cell-thin lining of your arterial walls — where it has direct biochemical activity.
eNOS is activated
Epicatechin activates eNOS — the enzyme your endothelial cells use to produce nitric oxide. The same enzyme targeted by several classes of blood pressure medication.
Blood pressure falls
Nitric oxide signals arterial smooth muscle cells to relax and widen. Blood flows with less resistance. Blood pressure falls. Effect measurable within 2–4 hours.
"The endothelium is not just a passive lining. It is the most important cardiovascular organ you have never been told about."
Luscher and Barton 1997, Endotheliology LiteratureThe research behind the claim
VitalCacao's cardiovascular positioning is built on three bodies of clinical evidence. Each is independently conducted, peer-reviewed and reproducible.
The largest and longest flavanol intervention trial ever conducted. 21,442 participants, 3.6 years follow-up, double-blind randomised controlled design. Participants received 600mg of cocoa flavanols daily.
A systematic review of 20 randomised controlled trials including 856 participants. Assessed the effect of flavanol-rich cacao on adults with normal to mildly elevated blood pressure.
Following review of the clinical evidence, the EFSA panel established that cocoa flavanols contribute to maintenance of normal endothelium-dependent vasodilation.
"If epicatechin were a drug, it would be a blockbuster. The challenge is that it comes from food — which makes it harder to patent, easier to ignore, and consistently underdosed."Consistent with commentary, Norman Hollenberg MD, Harvard Medical School
Why most cacao products don't work
The gap between what the research studied and what most people consume is significant. Understanding it explains why you may have tried cacao before without result.
Dutch-processing: how cacao loses its cardiovascular effect
Alkalization — Dutch-processing — was developed in the 19th century to reduce cacao's natural bitterness. It treats cacao with an alkaline solution that fundamentally alters the chemical structure of flavanols.
The result is a smoother, milder product. It is also a product from which 60–90% of the bioactive flavanols have been destroyed.
VitalCacao is never alkalized. The bitterness in your first cup is not a flaw — it is evidence that the flavanols are intact.
| VitalCacao | Supermarket Cocoa | Flavanol Capsule | Raw Cacao Powder | |
|---|---|---|---|---|
| Flavanols per serving | 600–800mg | 15–80mg | 200–400mg | 50–300mg (unverified) |
| Non-alkalized | ✓ Confirmed | ✗ Dutch-processed | △ Varies | △ Often alkalized |
| Third-party lab tested per batch | ✓ Every batch | ✗ Not tested | △ Some brands | ✗ Rarely |
| EFSA-compliant dose (200mg+) | ✓ 3× the minimum | ✗ Below threshold | ✓ Often yes | ✗ Dose unknown |
| Full flavanol matrix bioavailability | ✓ Whole cacao | ✗ Destroyed | ✗ Isolated extract | △ If non-alkalized |
| Built-in daily ritual | ✓ Morning cup | △ Possible | ✗ Capsule only | △ No protocol |
| Money-back guarantee | ✓ 90 days | — | △ 30 days typical | — |
cocoa
minimum
per cup
The dosing gap most people never know exists
The EFSA scientific opinion specifies 200mg daily for the authorised health claim. The COSMOS trial used 600mg per day. Most people who have tried cacao for blood pressure and seen no result were consuming approximately 30–80mg per serving from commercial cocoa.
Below the EFSA threshold. Below the clinical threshold. Not because cacao doesn't work — because the dose was wrong.
VitalCacao delivers 600–800mg per serving. This is a clinical dosing decision — the amount the evidence says works.
Why consistency is the mechanism
Cardiovascular adaptation is cumulative. A single cup produces a measurable effect. Thirty consecutive cups produce structural adaptation. The protocol matters as much as the product.
The Ritual Forms
Your endothelium begins receiving its first consistent daily flavanol signal. Plasma nitric oxide concentrations begin to rise. Some customers notice improved morning energy and reduced afternoon fatigue.
Vascular Adaptation Begins
Clinical studies show measurable increases in flow-mediated dilation at the 2–4 week mark. Blood pressure monitoring typically begins to show subtle changes.
Clinically Meaningful Change
The COSMOS trial's most significant subgroup results began to separate at the 6–8 week mark. This is where the polyphenol antioxidant complex begins producing measurable anti-inflammatory effects alongside the direct NO mechanism.
Structural Adaptation
Long-term flavanol intake is associated with reduced arterial stiffness, improved endothelial repair capacity, and lower inflammatory markers. The COSMOS trial's 27% reduction in cardiovascular mortality came from 3.6 years of consistent daily intake.
The science is clear.
Your first cup is next.
You now understand the mechanism, the research and the dosing. VitalCacao is built entirely around what the evidence says, and backed by a guarantee that reflects it.
